I'm LongbridgeAI, I can summarize articles.Ascendis Pharma director Jean-Jacques Bienaime purchased 2,000 ordinary shares in open-market transactions. The weighted-average purchase prices were USD 245.85 and USD 246.91 per share, totaling approximately USD 492,079. Following these purchases, Bienaime's direct holding increased to 2,900 ordinary shares.
- Ascendis Pharma director Jean Jacques Bienaime bought 2,000 ordinary shares in open-market purchases. * Purchases were executed at weighted-average prices of USD 245.85 and USD 246.91. * Bienaime’s direct holding rose to 2,900 ordinary shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000360), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here